FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence

by on September 9, 2018

FDA approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence. (Source: Food and Drug Administration)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Previous post:

Next post: